Role of TP53 mutations in relation to response to anti-ALK agents in EML4-ALK-translocated NSCLC patientsM. Canale,A. Delmonte,C. Dazzi,A. Gamboni, C. Casanova,M. Papi,M. Mariotti, N. De Luigi,M. A. Burgio,G. Minuti,D. Calistri,M. Bonafe,L. Crino,P. UliviAnnals of Oncology(2018)引用 0|浏览76暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要